用MELD3.0预测死亡率和肝硬化相关并发症:多中心队列分析
Jihye Lim1,2, Ji Hoon Kim1,3, Ahlim Lee1,4
1The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Gut and liver
|April 11, 2025
概括
末期肝病模型 (MELD) 3.0准确预测肝硬化患者的死亡率和肝脏并发症. 这个新的MELD 3.0得分在性能上超过了现有的模型.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 临床预测模型的临床预测模型.
- 肝脏疾病的预后 肝脏疾病的预后
背景情况:
- 肝硬化患者的结果需要准确的预后工具.
- 现有的模型,如Child-Pugh,MELD和MELDNa都有自己的局限性.
- 末期肝病模型 (MELD) 3.0是一种较新的评分系统.
研究的目的:
- 评估MELD 3.0.0的预测性能.
- 为了将MELD 3.0与Child-Pugh,ALBI等级,MELD和MELDNa.进行比较.
- 评估MELD 3.0与肝硬化相关并发症的关联.
主要方法:
- 对3314名肝硬化患者 (2013-2019) 的回顾性分析.
- 接受器运行特征曲线 (AUROC) 下面面积的比较,用于3个月死亡率.
- 基于MELD 3.0分数的肝硬化相关并发症风险的评估.
主要成果:
- 在预测3个月死亡率方面,MELD 3.0获得了最高的AUROC (0.851).
- 较高的MELD 3.0得分与死亡风险增加有显著的相关性.
- 增加MELD 3.0分数与患肝综合征,肝脑病和风的风险增加有关.
结论:
- MELD 3.0显示出对肝硬化死亡率的更高的预后准确性.
- MELD 3.0有效地预测了与肝硬化有关的各种并发症,特别是与脏有关的问题.
- MELD 3.0显示出作为肝脏疾病改善的临床预测工具的希望.
更多相关视频
06:09Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
Published on: July 21, 2023
1.0K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
185
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42
